

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * L-phenylalanine metabolic process (GO:0006558) | 6.55344118 |
| 2 | * erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 6.55344118 |
| 3 | L-phenylalanine catabolic process (GO:0006559) | 6.55344118 |
| 4 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 6.55344118 |
| 5 | aromatic amino acid family catabolic process (GO:0009074) | 5.89611475 |
| 6 | glyoxylate metabolic process (GO:0046487) | 5.79642769 |
| 7 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 5.46605866 |
| 8 | sulfur amino acid catabolic process (GO:0000098) | 5.45468149 |
| 9 | kynurenine metabolic process (GO:0070189) | 5.42579127 |
| 10 | cysteine metabolic process (GO:0006534) | 5.41463651 |
| 11 | tryptophan catabolic process (GO:0006569) | 5.34318198 |
| 12 | indole-containing compound catabolic process (GO:0042436) | 5.34318198 |
| 13 | indolalkylamine catabolic process (GO:0046218) | 5.34318198 |
| 14 | lysine metabolic process (GO:0006553) | 5.32454651 |
| 15 | lysine catabolic process (GO:0006554) | 5.32454651 |
| 16 | serine family amino acid catabolic process (GO:0009071) | 5.28018420 |
| 17 | Golgi transport vesicle coating (GO:0048200) | 5.09634799 |
| 18 | COPI coating of Golgi vesicle (GO:0048205) | 5.09634799 |
| 19 | tryptophan metabolic process (GO:0006568) | 5.00474784 |
| 20 | bile acid biosynthetic process (GO:0006699) | 4.96379566 |
| 21 | glycine metabolic process (GO:0006544) | 4.92905605 |
| 22 | urea cycle (GO:0000050) | 4.90272437 |
| 23 | urea metabolic process (GO:0019627) | 4.90272437 |
| 24 | negative regulation of fibrinolysis (GO:0051918) | 4.87440126 |
| 25 | homocysteine metabolic process (GO:0050667) | 4.65925793 |
| 26 | serine family amino acid metabolic process (GO:0009069) | 4.63211206 |
| 27 | alpha-linolenic acid metabolic process (GO:0036109) | 4.61658765 |
| 28 | amino-acid betaine metabolic process (GO:0006577) | 4.60112904 |
| 29 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.57778517 |
| 30 | nitrogen cycle metabolic process (GO:0071941) | 4.57483556 |
| 31 | high-density lipoprotein particle remodeling (GO:0034375) | 4.55762300 |
| 32 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.47775061 |
| 33 | protein carboxylation (GO:0018214) | 4.47775061 |
| 34 | regulation of fibrinolysis (GO:0051917) | 4.46345231 |
| 35 | alpha-amino acid catabolic process (GO:1901606) | 4.46016809 |
| 36 | serine family amino acid biosynthetic process (GO:0009070) | 4.39247471 |
| 37 | regulation of triglyceride catabolic process (GO:0010896) | 4.35944193 |
| 38 | * aromatic amino acid family metabolic process (GO:0009072) | 4.31477933 |
| 39 | protein maturation by protein folding (GO:0022417) | 4.28761531 |
| 40 | regulation of protein activation cascade (GO:2000257) | 4.28002171 |
| 41 | bile acid metabolic process (GO:0008206) | 4.26346666 |
| 42 | cellular amino acid catabolic process (GO:0009063) | 4.23935279 |
| 43 | complement activation, alternative pathway (GO:0006957) | 4.19679799 |
| 44 | cellular modified amino acid catabolic process (GO:0042219) | 4.17464682 |
| 45 | cellular ketone body metabolic process (GO:0046950) | 4.16350113 |
| 46 | regulation of cholesterol esterification (GO:0010872) | 4.12507071 |
| 47 | proline biosynthetic process (GO:0006561) | 4.09562351 |
| 48 | triglyceride homeostasis (GO:0070328) | 4.09148630 |
| 49 | acylglycerol homeostasis (GO:0055090) | 4.09148630 |
| 50 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 4.08099836 |
| 51 | negative regulation of cholesterol transport (GO:0032375) | 4.05205871 |
| 52 | negative regulation of sterol transport (GO:0032372) | 4.05205871 |
| 53 | ethanol oxidation (GO:0006069) | 4.01400229 |
| 54 | aspartate family amino acid catabolic process (GO:0009068) | 4.00871332 |
| 55 | regulation of complement activation (GO:0030449) | 3.99839210 |
| 56 | protein retention in ER lumen (GO:0006621) | 3.96904163 |
| 57 | 2-oxoglutarate metabolic process (GO:0006103) | 3.95775315 |
| 58 | coenzyme catabolic process (GO:0009109) | 3.93500546 |
| 59 | tyrosine metabolic process (GO:0006570) | 3.93239276 |
| 60 | short-chain fatty acid metabolic process (GO:0046459) | 3.92980967 |
| 61 | glutamate metabolic process (GO:0006536) | 3.89564743 |
| 62 | reverse cholesterol transport (GO:0043691) | 3.89516908 |
| 63 | fatty acid beta-oxidation (GO:0006635) | 3.88761927 |
| 64 | NADH metabolic process (GO:0006734) | 3.88701716 |
| 65 | plasma lipoprotein particle remodeling (GO:0034369) | 3.88597949 |
| 66 | protein-lipid complex remodeling (GO:0034368) | 3.88597949 |
| 67 | macromolecular complex remodeling (GO:0034367) | 3.88597949 |
| 68 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 3.87213195 |
| 69 | acetyl-CoA metabolic process (GO:0006084) | 3.82444003 |
| 70 | plasma lipoprotein particle clearance (GO:0034381) | 3.82335494 |
| 71 | drug catabolic process (GO:0042737) | 3.80223924 |
| 72 | carboxylic acid catabolic process (GO:0046395) | 3.79612942 |
| 73 | organic acid catabolic process (GO:0016054) | 3.79612942 |
| 74 | aldehyde catabolic process (GO:0046185) | 3.79088903 |
| 75 | arginine metabolic process (GO:0006525) | 3.75646992 |
| 76 | valine metabolic process (GO:0006573) | 3.73144257 |
| 77 | imidazole-containing compound metabolic process (GO:0052803) | 3.72190500 |
| 78 | fatty acid oxidation (GO:0019395) | 3.71162253 |
| 79 | indolalkylamine metabolic process (GO:0006586) | 3.69365860 |
| 80 | cellular glucuronidation (GO:0052695) | 3.68649844 |
| 81 | daunorubicin metabolic process (GO:0044597) | 3.68442472 |
| 82 | polyketide metabolic process (GO:0030638) | 3.68442472 |
| 83 | doxorubicin metabolic process (GO:0044598) | 3.68442472 |
| 84 | benzene-containing compound metabolic process (GO:0042537) | 3.67429189 |
| 85 | drug transmembrane transport (GO:0006855) | 3.66241539 |
| 86 | negative regulation of fatty acid biosynthetic process (GO:0045717) | 3.64922625 |
| 87 | phospholipid efflux (GO:0033700) | 3.64662814 |
| 88 | nucleobase-containing small molecule interconversion (GO:0015949) | 3.64511705 |
| 89 | urate metabolic process (GO:0046415) | 3.64357398 |
| 90 | lipid oxidation (GO:0034440) | 3.62316289 |
| 91 | carnitine metabolic process (GO:0009437) | 3.61555355 |
| 92 | amine catabolic process (GO:0009310) | 3.61030976 |
| 93 | cellular biogenic amine catabolic process (GO:0042402) | 3.61030976 |
| 94 | regulation of cholesterol homeostasis (GO:2000188) | 3.60501240 |
| 95 | ketone body metabolic process (GO:1902224) | 3.60124699 |
| 96 | heme transport (GO:0015886) | 3.59365601 |
| 97 | fatty acid catabolic process (GO:0009062) | 3.58028241 |
| 98 | monocarboxylic acid catabolic process (GO:0072329) | 3.56221418 |
| 99 | bile acid and bile salt transport (GO:0015721) | 3.56013880 |
| 100 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.54038971 |
| 101 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.54038971 |
| 102 | branched-chain amino acid catabolic process (GO:0009083) | 3.51938365 |
| 103 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.48406118 |
| 104 | desmosome organization (GO:0002934) | 3.46864306 |
| 105 | L-serine metabolic process (GO:0006563) | 3.40233308 |
| 106 | plasma lipoprotein particle assembly (GO:0034377) | 3.37137906 |
| 107 | response to nitrosative stress (GO:0051409) | 3.36954769 |
| 108 | branched-chain amino acid metabolic process (GO:0009081) | 3.36235630 |
| 109 | glutamine family amino acid biosynthetic process (GO:0009084) | 3.35971988 |
| 110 | proline metabolic process (GO:0006560) | 3.34866551 |
| 111 | cholesterol efflux (GO:0033344) | 3.34525325 |
| 112 | exogenous drug catabolic process (GO:0042738) | 3.34270086 |
| 113 | pentose-phosphate shunt (GO:0006098) | 3.33614716 |
| 114 | cholesterol homeostasis (GO:0042632) | 3.33025604 |
| 115 | GDP-mannose metabolic process (GO:0019673) | 3.31399846 |
| 116 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 3.23145674 |
| 117 | aminoglycoside antibiotic metabolic process (GO:0030647) | 3.20757942 |
| 118 | glucose catabolic process (GO:0006007) | 3.12809415 |
| 119 | NADPH regeneration (GO:0006740) | 3.05232102 |
| 120 | glycosphingolipid catabolic process (GO:0046479) | 3.05040742 |
| 121 | glycoside metabolic process (GO:0016137) | 2.97564829 |
| 122 | glycolipid catabolic process (GO:0019377) | 2.97073105 |
| 123 | tricarboxylic acid cycle (GO:0006099) | 2.96109732 |
| 124 | glucose 6-phosphate metabolic process (GO:0051156) | 2.95649049 |
| 125 | 4-hydroxyproline metabolic process (GO:0019471) | 2.89738360 |
| 126 | oxaloacetate metabolic process (GO:0006107) | 2.86751564 |
| 127 | peptidyl-proline hydroxylation (GO:0019511) | 2.84908836 |
| 128 | nucleotide-sugar biosynthetic process (GO:0009226) | 2.81272038 |
| 129 | protein hydroxylation (GO:0018126) | 2.81039590 |
| 130 | monosaccharide biosynthetic process (GO:0046364) | 2.78149362 |
| 131 | primary alcohol catabolic process (GO:0034310) | 2.76832951 |
| 132 | endoplasmic reticulum calcium ion homeostasis (GO:0032469) | 2.76764402 |
| 133 | negative regulation of release of cytochrome c from mitochondria (GO:0090201) | 2.74445794 |
| 134 | regulation of cholesterol biosynthetic process (GO:0045540) | 2.72695527 |
| 135 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 2.71411230 |
| 136 | barbed-end actin filament capping (GO:0051016) | 2.66182036 |
| 137 | protein localization to endosome (GO:0036010) | 2.65819318 |
| 138 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.65499738 |
| 139 | gluconeogenesis (GO:0006094) | 2.65417859 |
| 140 | ribosome assembly (GO:0042255) | 2.64195018 |
| 141 | hexose biosynthetic process (GO:0019319) | 2.62305108 |
| 142 | nuclear envelope reassembly (GO:0031468) | 2.60738834 |
| 143 | mitotic nuclear envelope reassembly (GO:0007084) | 2.60738834 |
| 144 | very-low-density lipoprotein particle assembly (GO:0034379) | 2.57544492 |
| 145 | fibrinolysis (GO:0042730) | 2.57330313 |
| 146 | positive regulation of mitochondrial calcium ion concentration (GO:0051561) | 2.56715741 |
| 147 | COPII vesicle coating (GO:0048208) | 2.55981739 |
| 148 | skin morphogenesis (GO:0043589) | 2.52358958 |
| 149 | regulation of translational fidelity (GO:0006450) | 2.51527083 |
| 150 | pinocytosis (GO:0006907) | 2.50633623 |
| 151 | epithelial cell-cell adhesion (GO:0090136) | 2.50533224 |
| 152 | regulation of mitochondrial translation (GO:0070129) | 2.50049102 |
| 153 | positive regulation of cellular amine metabolic process (GO:0033240) | 2.49833069 |
| 154 | oligosaccharide catabolic process (GO:0009313) | 2.48467780 |
| 155 | positive regulation of epidermal cell differentiation (GO:0045606) | 2.44064853 |
| 156 | mitochondrial fusion (GO:0008053) | 2.38861185 |
| 157 | fructose metabolic process (GO:0006000) | 2.38116468 |
| 158 | regulation of mammary gland epithelial cell proliferation (GO:0033599) | 2.35114086 |
| 159 | ceramide catabolic process (GO:0046514) | 2.35100046 |
| 160 | regulation of metalloenzyme activity (GO:0048552) | 2.34327285 |
| 161 | epoxygenase P450 pathway (GO:0019373) | 2.34315756 |
| 162 | regulation of early endosome to late endosome transport (GO:2000641) | 2.34091061 |
| 163 | NADP metabolic process (GO:0006739) | 2.33950282 |
| 164 | branching involved in mammary gland duct morphogenesis (GO:0060444) | 2.33443347 |
| 165 | formation of translation preinitiation complex (GO:0001731) | 2.32753408 |
| 166 | low-density lipoprotein particle clearance (GO:0034383) | 2.32659115 |
| 167 | positive regulation of keratinocyte differentiation (GO:0045618) | 2.32496839 |
| 168 | negative regulation of cell size (GO:0045792) | 2.30784399 |
| 169 | tricarboxylic acid metabolic process (GO:0072350) | 2.30152058 |
| 170 | pentose metabolic process (GO:0019321) | 2.30093551 |
| 171 | amyloid precursor protein catabolic process (GO:0042987) | 2.29183624 |
| 172 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 2.27784320 |
| 173 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 2.27308965 |
| 174 | folic acid metabolic process (GO:0046655) | 2.26833704 |
| 175 | regulation of cholesterol metabolic process (GO:0090181) | 2.25622209 |
| 176 | maternal placenta development (GO:0001893) | 2.25368565 |
| 177 | galactose catabolic process (GO:0019388) | 2.25260293 |
| 178 | cellular zinc ion homeostasis (GO:0006882) | 2.25196372 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 8.91017941 |
| 2 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 6.22219623 |
| 3 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 5.58668147 |
| 4 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 5.43861008 |
| 5 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 4.47705489 |
| 6 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 4.46473624 |
| 7 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 3.99259608 |
| 8 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 3.71942200 |
| 9 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.10823053 |
| 10 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.67702518 |
| 11 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.54221447 |
| 12 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.53366070 |
| 13 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 2.20200891 |
| 14 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.14699749 |
| 15 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 2.05908696 |
| 16 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.98328489 |
| 17 | E2F7_22180533_ChIP-Seq_HELA_Human | 1.97505138 |
| 18 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.92575996 |
| 19 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.71128667 |
| 20 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.70507953 |
| 21 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.67144083 |
| 22 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.66297550 |
| 23 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.66283533 |
| 24 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.64952090 |
| 25 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.61450495 |
| 26 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.59825265 |
| 27 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.57899848 |
| 28 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.56760040 |
| 29 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.56144293 |
| 30 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.53814751 |
| 31 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.53685083 |
| 32 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.53394534 |
| 33 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.52997718 |
| 34 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.50257078 |
| 35 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.48486271 |
| 36 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.40769351 |
| 37 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.40137186 |
| 38 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.32113626 |
| 39 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.32040525 |
| 40 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.30935688 |
| 41 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.27423120 |
| 42 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.26833728 |
| 43 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.26037226 |
| 44 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.25785441 |
| 45 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.24235610 |
| 46 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.24212854 |
| 47 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.21978756 |
| 48 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.20838578 |
| 49 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.20489492 |
| 50 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.16891249 |
| 51 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.16008397 |
| 52 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.16001872 |
| 53 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.14165742 |
| 54 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.14165742 |
| 55 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.13241991 |
| 56 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.11853927 |
| 57 | TBX5_21415370_ChIP-Seq_HL-1_Mouse | 1.11832036 |
| 58 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.11769663 |
| 59 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 1.11398485 |
| 60 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.09991514 |
| 61 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.08548031 |
| 62 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.08045152 |
| 63 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.07843098 |
| 64 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.07831908 |
| 65 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.07732338 |
| 66 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.07410427 |
| 67 | CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.05101215 |
| 68 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.04399615 |
| 69 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.03951256 |
| 70 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.03750481 |
| 71 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.02737095 |
| 72 | SOX2_18692474_ChIP-Seq_MEFs_Mouse | 1.02507296 |
| 73 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.02110516 |
| 74 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.02048512 |
| 75 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.01777337 |
| 76 | * OCT4_18692474_ChIP-Seq_MEFs_Mouse | 1.01555145 |
| 77 | TCFCP2L1_18555785_ChIP-Seq_MESCs_Mouse | 1.01357563 |
| 78 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 1.01048177 |
| 79 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.01001628 |
| 80 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 1.00439918 |
| 81 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.99939257 |
| 82 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.99399112 |
| 83 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.99101237 |
| 84 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.98790196 |
| 85 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 0.98414108 |
| 86 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.97092132 |
| 87 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.97048270 |
| 88 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.96784326 |
| 89 | DCP1A_22483619_ChIP-Seq_HELA_Human | 0.96771955 |
| 90 | ATF3_27146783_Chip-Seq_COLON_Human | 0.94271406 |
| 91 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 0.93978429 |
| 92 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.92852225 |
| 93 | XRN2_22483619_ChIP-Seq_HELA_Human | 0.92053564 |
| 94 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 0.90016119 |
| 95 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 0.89183246 |
| 96 | AR_21909140_ChIP-Seq_LNCAP_Human | 0.88998266 |
| 97 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.88971260 |
| 98 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 0.88611114 |
| 99 | * SRF_21415370_ChIP-Seq_HL-1_Mouse | 0.87402761 |
| 100 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.86457202 |
| 101 | * NELFA_20434984_ChIP-Seq_ESCs_Mouse | 0.85938355 |
| 102 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.83662341 |
| 103 | NACC1_18358816_ChIP-ChIP_MESCs_Mouse | 0.83594553 |
| 104 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.83043848 |
| 105 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 0.81958489 |
| 106 | GABP_19822575_ChIP-Seq_HepG2_Human | 0.81728981 |
| 107 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.80792611 |
| 108 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 0.80739710 |
| 109 | * SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.79870212 |
| 110 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 0.79165868 |
| 111 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.78670607 |
| 112 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.77198860 |
| 113 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 0.77035954 |
| 114 | * CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 0.76464893 |
| 115 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.76442914 |
| 116 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.75631155 |
| 117 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.75186467 |
| 118 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 0.73928706 |
| 119 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 0.73928706 |
| 120 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 0.73928706 |
| 121 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 0.73802236 |
| 122 | P68_20966046_ChIP-Seq_HELA_Human | 0.72995742 |
| 123 | * CTCF_21964334_Chip-Seq_Bcells_Human | 0.72389003 |
| 124 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.72079484 |
| 125 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.72016030 |
| 126 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 0.71661077 |
| 127 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.70593624 |
| 128 | * FOXP1_21924763_ChIP-Seq_HESCs_Human | 0.70541185 |
| 129 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 0.69527992 |
| 130 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 0.68592445 |
| 131 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 0.67072593 |
| 132 | MYC_22102868_ChIP-Seq_BL_Human | 0.67049640 |
| 133 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.65854908 |
| 134 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.64527846 |
| 135 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.63983089 |
| 136 | * POU5F1_18692474_ChIP-Seq_MESCs_Mouse | 0.63834113 |
| 137 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.63769020 |
| 138 | NANOG_18692474_ChIP-Seq_MEFs_Mouse | 0.63292412 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 7.53603963 |
| 2 | MP0005360_urolithiasis | 7.15922477 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 5.79885715 |
| 4 | MP0005365_abnormal_bile_salt | 5.54202145 |
| 5 | MP0003806_abnormal_nucleotide_metabolis | 4.65742740 |
| 6 | MP0008875_abnormal_xenobiotic_pharmacok | 4.38230815 |
| 7 | MP0010234_abnormal_vibrissa_follicle | 4.09458227 |
| 8 | MP0009840_abnormal_foam_cell | 3.31854420 |
| 9 | MP0003252_abnormal_bile_duct | 3.30803296 |
| 10 | MP0010329_abnormal_lipoprotein_level | 3.08682721 |
| 11 | * MP0005332_abnormal_amino_acid | 2.98806094 |
| 12 | MP0005083_abnormal_biliary_tract | 2.75579094 |
| 13 | MP0002877_abnormal_melanocyte_morpholog | 2.63679365 |
| 14 | MP0003195_calcinosis | 2.58126551 |
| 15 | MP0001666_abnormal_nutrient_absorption | 2.43860985 |
| 16 | MP0003191_abnormal_cellular_cholesterol | 2.43025342 |
| 17 | MP0004019_abnormal_vitamin_homeostasis | 2.37272011 |
| 18 | MP0004233_abnormal_muscle_weight | 2.19116357 |
| 19 | MP0002138_abnormal_hepatobiliary_system | 2.12981532 |
| 20 | MP0000609_abnormal_liver_physiology | 2.01953533 |
| 21 | * MP0005319_abnormal_enzyme/_coenzyme | 1.91741414 |
| 22 | MP0002118_abnormal_lipid_homeostasis | 1.84206644 |
| 23 | MP0005257_abnormal_intraocular_pressure | 1.83878303 |
| 24 | MP0003705_abnormal_hypodermis_morpholog | 1.83142780 |
| 25 | MP0003186_abnormal_redox_activity | 1.82620352 |
| 26 | MP0009780_abnormal_chondrocyte_physiolo | 1.70074770 |
| 27 | MP0009643_abnormal_urine_homeostasis | 1.69485498 |
| 28 | MP0001764_abnormal_homeostasis | 1.65511468 |
| 29 | MP0006036_abnormal_mitochondrial_physio | 1.61009930 |
| 30 | MP0008260_abnormal_autophagy | 1.59000094 |
| 31 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.54762144 |
| 32 | MP0004272_abnormal_basement_membrane | 1.53417020 |
| 33 | MP0008438_abnormal_cutaneous_collagen | 1.53113237 |
| 34 | MP0000678_abnormal_parathyroid_gland | 1.47259569 |
| 35 | MP0004264_abnormal_extraembryonic_tissu | 1.46178446 |
| 36 | MP0003868_abnormal_feces_composition | 1.38931034 |
| 37 | MP0000003_abnormal_adipose_tissue | 1.30953149 |
| 38 | MP0005076_abnormal_cell_differentiation | 1.30596600 |
| 39 | MP0003693_abnormal_embryo_hatching | 1.29945861 |
| 40 | MP0000598_abnormal_liver_morphology | 1.26472455 |
| 41 | MP0005670_abnormal_white_adipose | 1.26097728 |
| 42 | MP0000751_myopathy | 1.25685147 |
| 43 | MP0002060_abnormal_skin_morphology | 1.24715948 |
| 44 | MP0003011_delayed_dark_adaptation | 1.21841825 |
| 45 | MP0003950_abnormal_plasma_membrane | 1.21269068 |
| 46 | MP0001849_ear_inflammation | 1.19820338 |
| 47 | MP0003941_abnormal_skin_development | 1.16513783 |
| 48 | MP0005636_abnormal_mineral_homeostasis | 1.13772791 |
| 49 | MP0003656_abnormal_erythrocyte_physiolo | 1.11823493 |
| 50 | MP0000858_altered_metastatic_potential | 1.11438623 |
| 51 | MP0004782_abnormal_surfactant_physiolog | 1.10375750 |
| 52 | MP0005375_adipose_tissue_phenotype | 1.09820791 |
| 53 | MP0001216_abnormal_epidermal_layer | 1.08179755 |
| 54 | MP0005451_abnormal_body_composition | 1.07846308 |
| 55 | MP0000537_abnormal_urethra_morphology | 1.05334253 |
| 56 | MP0009697_abnormal_copulation | 1.04175271 |
| 57 | MP0000749_muscle_degeneration | 1.03856367 |
| 58 | MP0006035_abnormal_mitochondrial_morpho | 1.00772568 |
| 59 | MP0001727_abnormal_embryo_implantation | 1.00514401 |
| 60 | MP0000750_abnormal_muscle_regeneration | 0.98454746 |
| 61 | MP0001730_embryonic_growth_arrest | 0.97614416 |
| 62 | MP0010030_abnormal_orbit_morphology | 0.96763603 |
| 63 | MP0010368_abnormal_lymphatic_system | 0.95369630 |
| 64 | MP0001756_abnormal_urination | 0.95137160 |
| 65 | MP0005266_abnormal_metabolism | 0.95001417 |
| 66 | MP0002896_abnormal_bone_mineralization | 0.94604356 |
| 67 | MP0004130_abnormal_muscle_cell | 0.94450324 |
| 68 | MP0003123_paternal_imprinting | 0.94363451 |
| 69 | MP0000343_altered_response_to | 0.93288885 |
| 70 | MP0005666_abnormal_adipose_tissue | 0.92555910 |
| 71 | MP0001881_abnormal_mammary_gland | 0.92221841 |
| 72 | MP0002098_abnormal_vibrissa_morphology | 0.91862101 |
| 73 | MP0005409_darkened_coat_color | 0.91764405 |
| 74 | MP0000627_abnormal_mammary_gland | 0.89013423 |
| 75 | MP0002089_abnormal_postnatal_growth/wei | 0.88071582 |
| 76 | MP0002254_reproductive_system_inflammat | 0.87870822 |
| 77 | MP0003075_altered_response_to | 0.87629199 |
| 78 | MP0005376_homeostasis/metabolism_phenot | 0.86283111 |
| 79 | MP0000013_abnormal_adipose_tissue | 0.86200773 |
| 80 | MP0005330_cardiomyopathy | 0.85301367 |
| 81 | MP0000467_abnormal_esophagus_morphology | 0.84839462 |
| 82 | MP0009053_abnormal_anal_canal | 0.84706963 |
| 83 | MP0010678_abnormal_skin_adnexa | 0.84106321 |
| 84 | MP0009763_increased_sensitivity_to | 0.83919073 |
| 85 | * MP0009642_abnormal_blood_homeostasis | 0.82094218 |
| 86 | MP0008932_abnormal_embryonic_tissue | 0.81016282 |
| 87 | MP0009379_abnormal_foot_pigmentation | 0.80937200 |
| 88 | MP0000733_abnormal_muscle_development | 0.80769427 |
| 89 | MP0003111_abnormal_nucleus_morphology | 0.80627619 |
| 90 | MP0002269_muscular_atrophy | 0.79511466 |
| 91 | MP0002837_dystrophic_cardiac_calcinosis | 0.78344550 |
| 92 | MP0008469_abnormal_protein_level | 0.77365729 |
| 93 | MP0005084_abnormal_gallbladder_morpholo | 0.76836369 |
| 94 | MP0000462_abnormal_digestive_system | 0.76681806 |
| 95 | MP0005647_abnormal_sex_gland | 0.76126968 |
| 96 | MP0004858_abnormal_nervous_system | 0.75010755 |
| 97 | MP0000762_abnormal_tongue_morphology | 0.74855336 |
| 98 | MP0002078_abnormal_glucose_homeostasis | 0.74155806 |
| 99 | MP0001853_heart_inflammation | 0.73909936 |
| 100 | MP0002136_abnormal_kidney_physiology | 0.73505083 |
| 101 | MP0000759_abnormal_skeletal_muscle | 0.73260881 |
| 102 | MP0009764_decreased_sensitivity_to | 0.72145197 |
| 103 | MP0005220_abnormal_exocrine_pancreas | 0.71364198 |
| 104 | MP0010771_integument_phenotype | 0.70949469 |
| 105 | MP0004043_abnormal_pH_regulation | 0.70897744 |
| 106 | MP0000681_abnormal_thyroid_gland | 0.66542911 |
| 107 | MP0002080_prenatal_lethality | 0.66426824 |
| 108 | MP0003077_abnormal_cell_cycle | 0.65926489 |
| 109 | MP0002971_abnormal_brown_adipose | 0.65361040 |
| 110 | MP0001243_abnormal_dermal_layer | 0.63967479 |
| 111 | MP0005058_abnormal_lysosome_morphology | 0.61626030 |
| 112 | MP0003718_maternal_effect | 0.59676344 |
| 113 | MP0000604_amyloidosis | 0.56769104 |
| 114 | MP0003646_muscle_fatigue | 0.56760822 |
| 115 | MP0003638_abnormal_response/metabolism_ | 0.56503634 |
| 116 | MP0005334_abnormal_fat_pad | 0.56238311 |
| 117 | MP0002796_impaired_skin_barrier | 0.55583641 |
| 118 | MP0004185_abnormal_adipocyte_glucose | 0.55319941 |
| 119 | MP0003221_abnormal_cardiomyocyte_apopto | 0.54474427 |
| 120 | MP0005408_hypopigmentation | 0.54427133 |
| 121 | MP0005395_other_phenotype | 0.52579317 |
| 122 | MP0009765_abnormal_xenobiotic_induced | 0.51739817 |
| 123 | MP0005023_abnormal_wound_healing | 0.51103151 |
| 124 | MP0008873_increased_physiological_sensi | 0.48336187 |
| 125 | MP0002332_abnormal_exercise_endurance | 0.45371461 |
| 126 | MP0000358_abnormal_cell_content/ | 0.44751509 |
| 127 | MP0002970_abnormal_white_adipose | 0.44622129 |
| 128 | MP0005535_abnormal_body_temperature | 0.43740904 |
| 129 | MP0001661_extended_life_span | 0.43486025 |
| 130 | MP0001765_abnormal_ion_homeostasis | 0.43134991 |
| 131 | MP0009115_abnormal_fat_cell | 0.42353947 |
| 132 | MP0010352_gastrointestinal_tract_polyps | 0.42148214 |
| 133 | MP0005165_increased_susceptibility_to | 0.41301088 |
| 134 | MP0009672_abnormal_birth_weight | 0.39845540 |
| 135 | MP0002135_abnormal_kidney_morphology | 0.39200745 |
| 136 | MP0000639_abnormal_adrenal_gland | 0.38135918 |
| 137 | MP0002132_abnormal_respiratory_system | 0.37266633 |
| 138 | MP0003566_abnormal_cell_adhesion | 0.35481610 |
| 139 | MP0000747_muscle_weakness | 0.35094664 |
| 140 | MP0000249_abnormal_blood_vessel | 0.34490639 |
| 141 | MP0003453_abnormal_keratinocyte_physiol | 0.34318755 |
| 142 | MP0010630_abnormal_cardiac_muscle | 0.33856728 |
| 143 | MP0005501_abnormal_skin_physiology | 0.33328009 |
| 144 | MP0008872_abnormal_physiological_respon | 0.32967560 |
| 145 | * MP0003953_abnormal_hormone_level | 0.32684669 |
| 146 | MP0000230_abnormal_systemic_arterial | 0.32569168 |
| 147 | MP0008775_abnormal_heart_ventricle | 0.32533974 |
| 148 | MP0005448_abnormal_energy_balance | 0.31754208 |
| 149 | MP0001544_abnormal_cardiovascular_syste | 0.31650992 |
| 150 | MP0005385_cardiovascular_system_phenoty | 0.31650992 |
| 151 | MP0004957_abnormal_blastocyst_morpholog | 0.31202244 |
| 152 | MP0004087_abnormal_muscle_fiber | 0.31128523 |
| 153 | MP0002168_other_aberrant_phenotype | 0.30845736 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * Abnormality of aromatic amino acid family metabolism (HP:0004338) | 6.08798208 |
| 2 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 5.96688779 |
| 3 | Intrahepatic cholestasis (HP:0001406) | 5.84734377 |
| 4 | Deep venous thrombosis (HP:0002625) | 5.68922345 |
| 5 | Xanthomatosis (HP:0000991) | 5.38857162 |
| 6 | Hypobetalipoproteinemia (HP:0003563) | 5.31872580 |
| 7 | Hyperammonemia (HP:0001987) | 4.97824792 |
| 8 | Hyperglycinuria (HP:0003108) | 4.67448528 |
| 9 | Hyperglycinemia (HP:0002154) | 4.61809140 |
| 10 | Prolonged partial thromboplastin time (HP:0003645) | 4.58904447 |
| 11 | Ketosis (HP:0001946) | 4.40840139 |
| 12 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.39797228 |
| 13 | Abnormality of glycine metabolism (HP:0010895) | 4.36576951 |
| 14 | Abnormality of serine family amino acid metabolism (HP:0010894) | 4.36576951 |
| 15 | Hyperlipoproteinemia (HP:0010980) | 4.27498029 |
| 16 | Hypolipoproteinemia (HP:0010981) | 4.06885342 |
| 17 | Hypoglycemic coma (HP:0001325) | 4.03637879 |
| 18 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.91951007 |
| 19 | Complement deficiency (HP:0004431) | 3.87496025 |
| 20 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.79572186 |
| 21 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.78328896 |
| 22 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.72504858 |
| 23 | Vertebral compression fractures (HP:0002953) | 3.66505291 |
| 24 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.61667229 |
| 25 | Hypoalphalipoproteinemia (HP:0003233) | 3.58348499 |
| 26 | Abnormality of methionine metabolism (HP:0010901) | 3.55603258 |
| 27 | Ketoacidosis (HP:0001993) | 3.55228641 |
| 28 | Epidermoid cyst (HP:0200040) | 3.42178924 |
| 29 | Abnormality of serum amino acid levels (HP:0003112) | 3.40909584 |
| 30 | Joint hemorrhage (HP:0005261) | 3.39099065 |
| 31 | Delayed CNS myelination (HP:0002188) | 3.36015493 |
| 32 | Distal lower limb muscle weakness (HP:0009053) | 3.34643754 |
| 33 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.33297278 |
| 34 | Dicarboxylic aciduria (HP:0003215) | 3.32955259 |
| 35 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 3.32955259 |
| 36 | Gout (HP:0001997) | 3.31414432 |
| 37 | Fat malabsorption (HP:0002630) | 3.29759693 |
| 38 | Abnormality of the common coagulation pathway (HP:0010990) | 3.25437786 |
| 39 | Lethargy (HP:0001254) | 3.22975293 |
| 40 | Abnormality of nucleobase metabolism (HP:0010932) | 3.21717300 |
| 41 | Abnormality of glycolipid metabolism (HP:0010969) | 3.13204023 |
| 42 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.13204023 |
| 43 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.13204023 |
| 44 | Abnormality of the intrinsic pathway (HP:0010989) | 3.03402184 |
| 45 | Cerebral edema (HP:0002181) | 3.01062690 |
| 46 | Abnormality of complement system (HP:0005339) | 3.00727791 |
| 47 | Abnormality of purine metabolism (HP:0004352) | 2.96323521 |
| 48 | Metabolic acidosis (HP:0001942) | 2.94405745 |
| 49 | Malnutrition (HP:0004395) | 2.79164907 |
| 50 | Hyperbilirubinemia (HP:0002904) | 2.79089896 |
| 51 | Hypercholesterolemia (HP:0003124) | 2.78246661 |
| 52 | Premature rupture of membranes (HP:0001788) | 2.73864395 |
| 53 | Achilles tendon contracture (HP:0001771) | 2.73476317 |
| 54 | Generalized aminoaciduria (HP:0002909) | 2.69603699 |
| 55 | Spastic diplegia (HP:0001264) | 2.66121955 |
| 56 | Abnormality of glycolysis (HP:0004366) | 2.66065364 |
| 57 | Hypokinesia (HP:0002375) | 2.60555589 |
| 58 | Abnormality of the distal phalanges of the toes (HP:0010182) | 2.58834234 |
| 59 | Hepatocellular carcinoma (HP:0001402) | 2.55320677 |
| 60 | Late onset (HP:0003584) | 2.54390986 |
| 61 | Vomiting (HP:0002013) | 2.52945208 |
| 62 | Proximal tubulopathy (HP:0000114) | 2.49620821 |
| 63 | Neonatal onset (HP:0003623) | 2.47804877 |
| 64 | Trismus (HP:0000211) | 2.43621577 |
| 65 | Steatorrhea (HP:0002570) | 2.43216854 |
| 66 | Short nail (HP:0001799) | 2.42952132 |
| 67 | Increased serum pyruvate (HP:0003542) | 2.42828688 |
| 68 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.42484347 |
| 69 | Osteolytic defects of the hand bones (HP:0009699) | 2.42484347 |
| 70 | Myocardial infarction (HP:0001658) | 2.41050304 |
| 71 | Axonal loss (HP:0003447) | 2.40896425 |
| 72 | Hepatic necrosis (HP:0002605) | 2.40655837 |
| 73 | Progressive muscle weakness (HP:0003323) | 2.40048208 |
| 74 | Skin nodule (HP:0200036) | 2.39801030 |
| 75 | Nausea (HP:0002018) | 2.39044062 |
| 76 | Conjugated hyperbilirubinemia (HP:0002908) | 2.38367592 |
| 77 | J-shaped sella turcica (HP:0002680) | 2.38164637 |
| 78 | Irritability (HP:0000737) | 2.37879220 |
| 79 | Abnormal cartilage morphology (HP:0002763) | 2.36733848 |
| 80 | Hydroxyprolinuria (HP:0003080) | 2.34480518 |
| 81 | Abnormality of proline metabolism (HP:0010907) | 2.34480518 |
| 82 | Increased purine levels (HP:0004368) | 2.32613509 |
| 83 | Hyperuricemia (HP:0002149) | 2.32613509 |
| 84 | Increased connective tissue (HP:0009025) | 2.30628934 |
| 85 | Hypochromic microcytic anemia (HP:0004840) | 2.29628907 |
| 86 | Myoglobinuria (HP:0002913) | 2.27532059 |
| 87 | Hypoglycemic seizures (HP:0002173) | 2.22424032 |
| 88 | Prolonged neonatal jaundice (HP:0006579) | 2.21688639 |
| 89 | Flat acetabular roof (HP:0003180) | 2.21332624 |
| 90 | Vascular calcification (HP:0004934) | 2.20452502 |
| 91 | Nuclear cataract (HP:0100018) | 2.18297904 |
| 92 | Abnormal hemoglobin (HP:0011902) | 2.18180439 |
| 93 | Right ventricular cardiomyopathy (HP:0011663) | 2.17954827 |
| 94 | Ragged-red muscle fibers (HP:0003200) | 2.17553203 |
| 95 | Glycosuria (HP:0003076) | 2.17463085 |
| 96 | Abnormality of urine glucose concentration (HP:0011016) | 2.17463085 |
| 97 | Abnormality of the Achilles tendon (HP:0005109) | 2.16584736 |
| 98 | Reduced subcutaneous adipose tissue (HP:0003758) | 2.16113604 |
| 99 | Opisthotonus (HP:0002179) | 2.15405052 |
| 100 | Pancreatitis (HP:0001733) | 2.15040392 |
| 101 | Abnormality of the umbilical cord (HP:0010881) | 2.13616147 |
| 102 | Abdominal distention (HP:0003270) | 2.13339858 |
| 103 | Brushfield spots (HP:0001088) | 2.12703050 |
| 104 | Asymmetry of the thorax (HP:0001555) | 2.12520958 |
| 105 | Cholelithiasis (HP:0001081) | 2.09770137 |
| 106 | Mitral stenosis (HP:0001718) | 2.09347885 |
| 107 | Distal lower limb amyotrophy (HP:0008944) | 2.09322377 |
| 108 | Esophageal varix (HP:0002040) | 2.09282661 |
| 109 | Protrusio acetabuli (HP:0003179) | 2.08310144 |
| 110 | Spinal cord compression (HP:0002176) | 2.05892644 |
| 111 | Acute encephalopathy (HP:0006846) | 2.05471233 |
| 112 | Spontaneous abortion (HP:0005268) | 2.04949035 |
| 113 | Hyperacusis (HP:0010780) | 2.03928195 |
| 114 | Vacuolated lymphocytes (HP:0001922) | 2.03211208 |
| 115 | Micronodular cirrhosis (HP:0001413) | 2.02603393 |
| 116 | Alkalosis (HP:0001948) | 2.02407289 |
| 117 | Reduced antithrombin III activity (HP:0001976) | 2.02219632 |
| 118 | Mucopolysacchariduria (HP:0008155) | 2.01284638 |
| 119 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.01284638 |
| 120 | Multiple enchondromatosis (HP:0005701) | 2.01047896 |
| 121 | Abnormality of iron homeostasis (HP:0011031) | 2.00761512 |
| 122 | Rhabdomyolysis (HP:0003201) | 2.00580834 |
| 123 | Abnormal gallbladder morphology (HP:0012437) | 1.98371167 |
| 124 | Glomerulonephritis (HP:0000099) | 1.98115156 |
| 125 | Hyperparathyroidism (HP:0000843) | 1.98079648 |
| 126 | Increased muscle lipid content (HP:0009058) | 1.97660987 |
| 127 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.97624900 |
| 128 | Cardiovascular calcification (HP:0011915) | 1.97494486 |
| 129 | Back pain (HP:0003418) | 1.97398543 |
| 130 | Rough bone trabeculation (HP:0100670) | 1.96070041 |
| 131 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 1.96036673 |
| 132 | Dysostosis multiplex (HP:0000943) | 1.95237023 |
| 133 | Systemic lupus erythematosus (HP:0002725) | 1.94802846 |
| 134 | Upper limb amyotrophy (HP:0009129) | 1.93609750 |
| 135 | Distal upper limb amyotrophy (HP:0007149) | 1.93609750 |
| 136 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.92819718 |
| 137 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.91892445 |
| 138 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.91892445 |
| 139 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.91892445 |
| 140 | Generalized amyotrophy (HP:0003700) | 1.90628784 |
| 141 | Abnormality of carpal bone ossification (HP:0006257) | 1.89668613 |
| 142 | Abnormal gallbladder physiology (HP:0012438) | 1.87978209 |
| 143 | Cholecystitis (HP:0001082) | 1.87978209 |
| 144 | Sensorimotor neuropathy (HP:0007141) | 1.86656188 |
| 145 | Multiple lipomas (HP:0001012) | 1.86309068 |
| 146 | Abnormalities of placenta or umbilical cord (HP:0001194) | 1.86291836 |
| 147 | Hemorrhage of the eye (HP:0011885) | 1.86036376 |
| 148 | Testicular atrophy (HP:0000029) | 1.82899451 |
| 149 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.82765687 |
| 150 | Increased serum ferritin (HP:0003281) | 1.82743298 |
| 151 | Elbow flexion contracture (HP:0002987) | 1.81160024 |
| 152 | Lactic acidosis (HP:0003128) | 1.80658956 |
| 153 | Ulnar bowing (HP:0003031) | 1.80358934 |
| 154 | CNS demyelination (HP:0007305) | 1.79898781 |
| 155 | Menorrhagia (HP:0000132) | 1.78393588 |
| 156 | Rickets (HP:0002748) | 1.78383127 |
| 157 | Abnormal trabecular bone morphology (HP:0100671) | 1.77026460 |
| 158 | Bone pain (HP:0002653) | 1.76617413 |
| 159 | Paraparesis (HP:0002385) | 1.73094556 |
| 160 | Exercise-induced myalgia (HP:0003738) | 1.72659804 |
| 161 | Cardiomegaly (HP:0001640) | 1.71253455 |
| 162 | Fasciculations (HP:0002380) | 1.70942293 |
| 163 | Mildly elevated creatine phosphokinase (HP:0008180) | 1.69707126 |
| 164 | Cervical subluxation (HP:0003308) | 1.69226420 |
| 165 | Myopathic facies (HP:0002058) | 1.67102145 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 6.69926343 |
| 2 | PKN2 | 3.61423442 |
| 3 | IRAK3 | 3.57345954 |
| 4 | TRIB3 | 3.24695070 |
| 5 | ERN1 | 3.20682766 |
| 6 | NME2 | 3.14049363 |
| 7 | TESK1 | 2.65920501 |
| 8 | FLT3 | 2.60343543 |
| 9 | MAP3K11 | 2.58474456 |
| 10 | FGFR4 | 2.58453961 |
| 11 | SIK1 | 2.52443947 |
| 12 | NEK1 | 2.22019731 |
| 13 | PBK | 2.14280787 |
| 14 | SMG1 | 2.09517306 |
| 15 | KDR | 1.98082479 |
| 16 | LIMK1 | 1.69736986 |
| 17 | MAP3K12 | 1.68119527 |
| 18 | TLK1 | 1.67429899 |
| 19 | EPHA2 | 1.64634997 |
| 20 | STK38L | 1.63415617 |
| 21 | MAPK11 | 1.55309652 |
| 22 | VRK2 | 1.49247110 |
| 23 | MST1R | 1.48185402 |
| 24 | PINK1 | 1.45886644 |
| 25 | MAPKAPK3 | 1.42023695 |
| 26 | MAP2K3 | 1.40998978 |
| 27 | LATS2 | 1.36485153 |
| 28 | NEK9 | 1.34639698 |
| 29 | TESK2 | 1.34192989 |
| 30 | PIM2 | 1.21792118 |
| 31 | EIF2AK1 | 1.17493837 |
| 32 | ERBB4 | 1.17453782 |
| 33 | TTN | 1.12477806 |
| 34 | GRK6 | 1.11935734 |
| 35 | PDK4 | 1.11888911 |
| 36 | PDK3 | 1.11888911 |
| 37 | ILK | 1.11433155 |
| 38 | ABL2 | 1.07533721 |
| 39 | MST4 | 1.04995182 |
| 40 | MAP3K10 | 1.04144987 |
| 41 | WEE1 | 1.03458372 |
| 42 | LMTK2 | 1.03371801 |
| 43 | MAP2K6 | 1.02455337 |
| 44 | TIE1 | 1.00719115 |
| 45 | MAP3K3 | 0.98668058 |
| 46 | DYRK1B | 0.97678341 |
| 47 | MAP2K2 | 0.95338889 |
| 48 | PTK6 | 0.94960414 |
| 49 | PRPF4B | 0.91280141 |
| 50 | PIK3CG | 0.88686727 |
| 51 | ICK | 0.88379710 |
| 52 | TYK2 | 0.87812551 |
| 53 | WNK4 | 0.86486850 |
| 54 | NME1 | 0.86460720 |
| 55 | RPS6KB2 | 0.85114864 |
| 56 | PRKCI | 0.84542666 |
| 57 | CDK8 | 0.81185881 |
| 58 | BUB1 | 0.78246591 |
| 59 | DAPK3 | 0.78243173 |
| 60 | RPS6KA4 | 0.75574426 |
| 61 | TBK1 | 0.75126871 |
| 62 | MAPK15 | 0.74615077 |
| 63 | TAOK2 | 0.73918594 |
| 64 | SCYL2 | 0.73496848 |
| 65 | BRSK1 | 0.72488747 |
| 66 | PAK4 | 0.71669648 |
| 67 | MATK | 0.70810770 |
| 68 | PRKAA2 | 0.70215901 |
| 69 | MAP2K4 | 0.69749972 |
| 70 | PDPK1 | 0.68562839 |
| 71 | LRRK2 | 0.68074262 |
| 72 | MUSK | 0.67641287 |
| 73 | DAPK1 | 0.67574560 |
| 74 | CDK7 | 0.67367723 |
| 75 | TGFBR1 | 0.67175197 |
| 76 | MAP3K2 | 0.67015129 |
| 77 | CDK4 | 0.66968204 |
| 78 | TGFBR2 | 0.66474951 |
| 79 | PDK2 | 0.65981980 |
| 80 | MAP3K8 | 0.65728152 |
| 81 | TAOK3 | 0.65263796 |
| 82 | STK16 | 0.65141860 |
| 83 | ARAF | 0.64775717 |
| 84 | PTK2 | 0.64308971 |
| 85 | PDGFRA | 0.62085532 |
| 86 | DDR2 | 0.62056429 |
| 87 | MAP3K7 | 0.61906639 |
| 88 | CDK6 | 0.61549927 |
| 89 | BMX | 0.59657475 |
| 90 | PRKG2 | 0.59639032 |
| 91 | JAK2 | 0.58636198 |
| 92 | LATS1 | 0.58153479 |
| 93 | MET | 0.57809311 |
| 94 | MYLK | 0.57592602 |
| 95 | CDK12 | 0.56752338 |
| 96 | GSK3A | 0.55407733 |
| 97 | TSSK6 | 0.54017738 |
| 98 | AURKA | 0.52431957 |
| 99 | MTOR | 0.52088944 |
| 100 | TTK | 0.51759745 |
| 101 | MAP3K1 | 0.51412362 |
| 102 | MAPK4 | 0.51151454 |
| 103 | DYRK3 | 0.49831460 |
| 104 | PRKAA1 | 0.49450086 |
| 105 | MAP2K1 | 0.48791571 |
| 106 | ERBB2 | 0.47779615 |
| 107 | EIF2AK3 | 0.47330823 |
| 108 | MAP3K5 | 0.46662944 |
| 109 | PHKG1 | 0.45695502 |
| 110 | PHKG2 | 0.45695502 |
| 111 | INSRR | 0.45644374 |
| 112 | AURKB | 0.44845904 |
| 113 | RIPK1 | 0.44631812 |
| 114 | PIM1 | 0.44597856 |
| 115 | BRAF | 0.44336566 |
| 116 | * CAMK2G | 0.43826546 |
| 117 | FER | 0.43130688 |
| 118 | KSR2 | 0.42064770 |
| 119 | EPHB1 | 0.41922952 |
| 120 | CSK | 0.41793902 |
| 121 | EPHB2 | 0.41123073 |
| 122 | CAMK2D | 0.40781264 |
| 123 | MAP3K6 | 0.40320049 |
| 124 | EEF2K | 0.40214432 |
| 125 | ACVR1B | 0.40165852 |
| 126 | STK10 | 0.39741446 |
| 127 | ZAP70 | 0.38645640 |
| 128 | PRKD3 | 0.38072187 |
| 129 | PRKACG | 0.38037398 |
| 130 | IRAK2 | 0.37688898 |
| 131 | PAK1 | 0.37512770 |
| 132 | NEK2 | 0.37432827 |
| 133 | MAPKAPK2 | 0.36826047 |
| 134 | MAP3K9 | 0.36514805 |
| 135 | AKT2 | 0.36220483 |
| 136 | TRPM7 | 0.35987165 |
| 137 | STK38 | 0.32939010 |
| 138 | NEK6 | 0.32886014 |
| 139 | CDK9 | 0.31996567 |
| 140 | NTRK1 | 0.31203530 |
| 141 | SRPK1 | 0.30981525 |
| 142 | PRKD2 | 0.27978767 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.71986445 |
| 2 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.28634029 |
| 3 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.21160344 |
| 4 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.03136517 |
| 5 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.96851286 |
| 6 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.90493331 |
| 7 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.66026305 |
| 8 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.62998859 |
| 9 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.55799584 |
| 10 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.52382565 |
| 11 | Other glycan degradation_Homo sapiens_hsa00511 | 2.47867158 |
| 12 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.45686227 |
| 13 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.36085485 |
| 14 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.27022002 |
| 15 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.16342714 |
| 16 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.09193335 |
| 17 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.06881756 |
| 18 | Peroxisome_Homo sapiens_hsa04146 | 2.06234415 |
| 19 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.85446991 |
| 20 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.77489675 |
| 21 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.73936227 |
| 22 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.73374933 |
| 23 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.72450295 |
| 24 | Sulfur relay system_Homo sapiens_hsa04122 | 1.70436961 |
| 25 | Carbon metabolism_Homo sapiens_hsa01200 | 1.69148310 |
| 26 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.69145223 |
| 27 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.69110470 |
| 28 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.68306450 |
| 29 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.67430231 |
| 30 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.66665898 |
| 31 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.65693657 |
| 32 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.64518360 |
| 33 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.64351305 |
| 34 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.59145964 |
| 35 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.58667531 |
| 36 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.57096211 |
| 37 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.56720782 |
| 38 | Histidine metabolism_Homo sapiens_hsa00340 | 1.53413736 |
| 39 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.44245371 |
| 40 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.39112959 |
| 41 | Retinol metabolism_Homo sapiens_hsa00830 | 1.37629815 |
| 42 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.36742854 |
| 43 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.34626666 |
| 44 | * Folate biosynthesis_Homo sapiens_hsa00790 | 1.33223112 |
| 45 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.31011722 |
| 46 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.29310371 |
| 47 | Bile secretion_Homo sapiens_hsa04976 | 1.27896554 |
| 48 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.26921127 |
| 49 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.24831697 |
| 50 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.22698234 |
| 51 | Lysosome_Homo sapiens_hsa04142 | 1.22019636 |
| 52 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.20644692 |
| 53 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.16354490 |
| 54 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.15628666 |
| 55 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.11795017 |
| 56 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.10963800 |
| 57 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.04563806 |
| 58 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.03986338 |
| 59 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.99404173 |
| 60 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.95910771 |
| 61 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.93137229 |
| 62 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.88543909 |
| 63 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.86118785 |
| 64 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.83087215 |
| 65 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.80196030 |
| 66 | ABC transporters_Homo sapiens_hsa02010 | 0.79750135 |
| 67 | Lysine degradation_Homo sapiens_hsa00310 | 0.79510955 |
| 68 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.78430334 |
| 69 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.76654458 |
| 70 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.76339121 |
| 71 | Base excision repair_Homo sapiens_hsa03410 | 0.67958851 |
| 72 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.66174074 |
| 73 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.64009840 |
| 74 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.61574035 |
| 75 | Mineral absorption_Homo sapiens_hsa04978 | 0.60403520 |
| 76 | Galactose metabolism_Homo sapiens_hsa00052 | 0.59717647 |
| 77 | * Metabolic pathways_Homo sapiens_hsa01100 | 0.59458794 |
| 78 | Ribosome_Homo sapiens_hsa03010 | 0.50161113 |
| 79 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.49136996 |
| 80 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.42438603 |
| 81 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.42000054 |
| 82 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.39794223 |
| 83 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.38848762 |
| 84 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.36095512 |
| 85 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.34407642 |
| 86 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.33226864 |
| 87 | Parkinsons disease_Homo sapiens_hsa05012 | 0.31793802 |
| 88 | Shigellosis_Homo sapiens_hsa05131 | 0.30922153 |
| 89 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.29788817 |
| 90 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.28683870 |
| 91 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.27275991 |
| 92 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.26037305 |
| 93 | Hepatitis C_Homo sapiens_hsa05160 | 0.25739367 |
| 94 | Tight junction_Homo sapiens_hsa04530 | 0.23792788 |
| 95 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.23699656 |
| 96 | Proteasome_Homo sapiens_hsa03050 | 0.23480120 |
| 97 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.22272714 |
| 98 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.21064167 |
| 99 | Insulin resistance_Homo sapiens_hsa04931 | 0.18952794 |
| 100 | Prion diseases_Homo sapiens_hsa05020 | 0.15461457 |
| 101 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.12073726 |
| 102 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.11666131 |
| 103 | Bladder cancer_Homo sapiens_hsa05219 | 0.07618226 |
| 104 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.06854409 |
| 105 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.06609490 |
| 106 | Huntingtons disease_Homo sapiens_hsa05016 | 0.05498119 |
| 107 | DNA replication_Homo sapiens_hsa03030 | 0.05042733 |
| 108 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.05035544 |
| 109 | Alzheimers disease_Homo sapiens_hsa05010 | 0.01724748 |
| 110 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.01468373 |
| 111 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | -0.0864609 |
| 112 | Renin-angiotensin system_Homo sapiens_hsa04614 | -0.0683314 |
| 113 | Thyroid cancer_Homo sapiens_hsa05216 | -0.0522423 |
| 114 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | -0.0497128 |
| 115 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | -0.0453997 |
| 116 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | -0.0433987 |
| 117 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | -0.0407598 |
| 118 | Mismatch repair_Homo sapiens_hsa03430 | -0.0242381 |
| 119 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.0145450 |

